CCL2 and neoplasm: Mechanistically, imperatorin can directly bind with CREB1 and inhibits its phosphorylation and interaction with TGFβ2 promoter, then inactivates extracellular signal‐regulated kinases (ERK) signaling and fibroblasts‐secreted CCL2 to block tumor angiogenesis and metastasis.